Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Non-Current Deferred Tax Liability (2016 - 2022)

ImmunityBio (IBRX) has disclosed Non-Current Deferred Tax Liability for 7 consecutive years, with $162000.0 as the latest value for Q2 2022.

  • Quarterly Non-Current Deferred Tax Liability fell 4.71% to $162000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $162000.0 through Jun 2022, down 4.71% year-over-year, with the annual reading at $162000.0 for FY2021, 4.71% down from the prior year.
  • Non-Current Deferred Tax Liability for Q2 2022 was $162000.0 at ImmunityBio, roughly flat from $162000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $374000.0 in Q1 2018, with the low at $122000.0 in Q3 2018.
  • Average Non-Current Deferred Tax Liability over 4 years is $191200.0, with a median of $170000.0 recorded in 2020.
  • The sharpest move saw Non-Current Deferred Tax Liability plummeted 82.09% in 2018, then decreased 4.71% in 2021.
  • Over 4 years, Non-Current Deferred Tax Liability stood at $122000.0 in 2018, then skyrocketed by 39.34% to $170000.0 in 2020, then fell by 4.71% to $162000.0 in 2021, then changed by 0.0% to $162000.0 in 2022.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $162000.0, $162000.0, and $162000.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.